Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02438839 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Curative Chemoradiation of Low Rectal Cancer

Study acronym: WW2
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Enrollment target: estimated 105 to confirmed 108v16
  2. Study completion date: Dec 2024 to Dec 2026v15
  3. 2 versions Re-verified since May 19, 2023, no change to tracked fieldsv13-v14
  4. Primary completion date changed from estimate of Apr 2022 to Mar 17, 2022v12
  5. Primary completion date: Dec 2021 to Apr 2022v11
Show 9 earlier versionsHide 9 earlier versions
  1. Re-verified, no change to tracked fieldsv10
  2. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 5 of 5 sites
    v9
  3. Primary completion date: Dec 2019 to Dec 2021
    • Study completion date: Dec 2022 to Dec 2024
    v8
  4. Re-verified, no change to tracked fieldsv7
  5. Start date: Apr 2015 to Sep 2015v6
  6. Study completion date: Dec 2022v5
  7. 3 versions Re-verified since Oct 28, 2015, no change to tracked fieldsv2-v4
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of the present study is to investigate whether curative chemoradiation of low rectal cancer is feasible, safe and effective in a multicenter study with results comparable to those of single center studies. Results from previous studies indicate that a considerable fraction of patients with low rectal cancer can be cured by a combination of radiation and chemotherapy alone and thus be spared from operation.
Trial Details
NCT Number NCT02438839
Lead Sponsor Vejle Hospital
Conditions
(from sponsor)		 Rectal Cancer
Related terms Rectal Neoplasms
Enrollment 108 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov